THE ESTIMATION OF WHOLE-BLOOD VISCOSITY BY A POROUS BED METHOD

被引:9
作者
CROWLEY, JP
VALERI, CR
METZGER, J
GRAY, A
SCHOONEMAN, F
MAN, NK
MERRILL, E
机构
[1] RHODE ISL HOSP,DEPT CLIN HEMATOL,PROVIDENCE,RI 02902
[2] BROWN UNIV,DEPT MED,PROVIDENCE,RI 02912
[3] MIT,CAMBRIDGE,MA 02139
[4] BOSTON UNIV,SCH MED,NAVAL BLOOD RES LAB,BOSTON,MA 02118
[5] REG BLOOD TRANSFUS CTR,NANCY,FRANCE
[6] HOP NECKER ENFANTS MALAD,DEPT NEPHROL,F-75730 PARIS 15,FRANCE
关键词
D O I
10.1093/ajcp/96.6.729
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A significant impediment in determining the relative contribution of whole blood viscosity to the pathogenesis of cardiovascular and cerebrovascular disease has been the lack of an uncomplicated method to measure whole blood viscosity. To address this problem, a simplified porous bed viscometer has been developed to measure whole blood viscosity. Whole blood is passed through a porous bed of branching channels with a mean pore diameter of 69.6 +/- 20.2-mu-m and an estimated mean shear rate of 19.6 seconds-1. The effects of sample collection, sample storage, and temperature are described. The mean whole blood viscosity of 242 healthy persons was 22.7 +/- 5.3 seconds, which, when corrected to centipoise using Darcy's equation, corresponds to an apparent viscosity of 5.7 +/- 1.3 cp. There was a significant difference in the whole blood viscosity of normal men and women related to their different packed cell volumes. Platelets and granulocytes influenced whole blood viscosity in proportion to their contribution to the total packed cell volume. Fibrinogen levels did not significantly influence measured whole blood viscosity, which is consistent with the disaggregating conditions and the mean shear rate of the instrument. The porous bed viscometer is a convenient means to measure whole blood viscosity and it should be useful as a screening test for clinical and epidemiologic studies.
引用
收藏
页码:729 / 737
页数:9
相关论文
共 37 条
[1]   INFLUENCE OF RISK-FACTORS AND COAGULATION PHENOMENA ON THE FLUIDITY OF BLOOD IN CHRONIC ARTERIAL OCCLUSIVE DISEASE - EFFECTS OF PENTOXIFYLLINE [J].
ANGELKORT, B ;
KIESEWETTER, H .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1981, 41 :185-188
[2]  
BADA HS, 1986, AM J MED SCI, V29, P157
[3]  
BAER MR, 1985, CANCER, V56, P2865, DOI 10.1002/1097-0142(19851215)56:12<2865::AID-CNCR2820561225>3.0.CO
[4]  
2-6
[5]   EFFECTS OF THEOPHYLLINE ON ERYTHROPOIETIN PRODUCTION IN NORMAL SUBJECTS AND IN PATIENTS WITH ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION [J].
BAKRIS, GL ;
SAUTER, ER ;
HUSSEY, JL ;
FISHER, JW ;
GABER, AO ;
WINSETT, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (02) :86-90
[6]   PREDICTION OF BLOOD FLOW IN TUBES WITH DIAMETERS AS SMALL AS 29-MU [J].
BARBEE, JH ;
COKELET, GR .
MICROVASCULAR RESEARCH, 1971, 3 (01) :17-&
[7]   THE RHEOLOGY OF HUMAN BLOOD - MEASUREMENT NEAR AND AT ZERO SHEAR RATE [J].
COKELET, GR ;
MERRILL, EW ;
GILLILAND, ER ;
SHIN, H ;
BRITTEN, A ;
WELLS, RE .
TRANSACTIONS OF THE SOCIETY OF RHEOLOGY, 1963, 7 :303-317
[8]  
CROUCH J D, 1986, Current Surgery, V43, P395
[9]   CEREBRAL THROMBOSIS IN SMOKERS POLYCYTHEMIA [J].
DOLL, DC ;
GREENBERG, BR .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (06) :786-787
[10]   RELATIONSHIP OF PLASMA FIBRINOGEN, ERYTHROCYTE FLEXIBILITY AND BLOOD-VISCOSITY [J].
DUPONT, PA ;
SIRS, JA .
THROMBOSIS AND HAEMOSTASIS, 1977, 38 (03) :660-667